Triple-Drug combo aims to improve diabetes control and weight loss
Disease control
Not yet recruiting
This study tests a new combination drug called TriGlytza-01 in overweight adults with type 2 diabetes whose blood sugar is not well controlled by metformin alone. The trial compares TriGlytza-01 to standard metformin over 16 weeks, measuring safety, blood sugar levels, and body w…
Phase: PHASE2 • Sponsor: Myopharm Limited • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC